NCT04177316View on ClinicalTrials.gov

Hypermethylation of VTRNA2-1 Promoter in HCC Outcome

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

November 15, 2019

Study Completion Date

November 15, 2019

Conditions
Hepatocellular Carcinoma Resectable
Trial Locations (1)

333

Ming-Chin Yu, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT04177316 - Hypermethylation of VTRNA2-1 Promoter in HCC Outcome | Biotech Hunter | Biotech Hunter